Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-03-25 | Ms. Burgess is a director whose term expires in 2022. The Audit Committee is comprised of Ms. Burgess, among others. The Compensation and Development Committee is comprised of Ms. Burgess, among others. The Compliance Committee is comprised of Ms. Burgess, among others. The Nominating and Corporate Governance Committee is comprised of Ms. Burgess, among others. The 2021 Director Compensation Table shows Ms. Burgess received total compensation of $174,993. |
| 2023-03-20 | Vice President, Finance and Chief Financial Officer, Americas Region of Medtronic Inc., a medical technology company, since March 2015. The Audit Committee is comprised of Ms. Burgess (Chair), Mr. Dearth, Dr. Delgado, Mr. Lawton, Ms. Reed and Mr. Wehmer, all of whom are financially literate and are independent directors in accordance with the rules of the New York Stock Exchange and the SEC and as described below under “Director Independence.” The Compliance Committee is comprised of Ms. Burgess, Mr. Dearth, Dr. Delgado, Mr. Lawton, Ms. Reed (Chair) and Mr. Wehmer, all of whom are independent directors in accordance with the rules of the New York Stock Exchange and as described below under “Director Independence.” The Human Capital and Compensation Committee is comprised of Ms. Burgess, Mr. Dearth, Dr. Delgado, Mr. Lawton (Chair), Ms. Reed and Mr. Wehmer, all of whom are independent directors in accordance with the rules of the New York Stock Exchange and the SEC and as described below under “Director Independence.” The Nominating and Corporate Governance Committee is comprised of Ms. Burgess, Mr. Dearth, Dr. Delgado (Chair), Mr. Lawton, Ms. Reed and Mr. Wehmer, all of whom are independent directors in accordance with the rules of the New York Stock Exchange and as described below under “Director Independence.” The table below summarizes the compensation paid by the Company to Non-Employee Directors for the fiscal year ended December 31, 2022. Lorinda A. Burgess, Randall S. Dearth, Joaquin Delgado, Gregory E. Lawton, Jan Stern Reed and Edward J. Wehmer were paid annual retainer fees and stock awards. |
| 2024-03-26 | Lorinda A. Burgess Age: 61 Director Since: 2021 Audit Committee: Chair Compliance Committee: Member Human Capital and Compensation Committee: Member Nominating and Corporate Governance Committee: Member 2023 Director Compensation Table: $244,974 total compensation |
| 2025-03-25 | Experience: Vice President, Finance and Chief Financial Officer, Americas Region of Medtronic Inc., a medical technology company, from March 2015 through June 2023. |
Data sourced from SEC filings. Last updated: 2025-08-30